HUTCHMED (China) (HCM) Interest Expenses (2014 - 2026)
HUTCHMED (China) (HCM) posted quarterly Interest Expenses of $3.4 million for Q2 2025, down 56.64% year-over-year from $7.9 million in Q2 2024, and down 56.64% quarter-over-quarter from $7.9 million in Q2 2024.
HUTCHMED (China) (HCM) Interest Expenses (2014 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Interest Expenses for 11 consecutive years, with $3.4 million the latest figure, recorded in Q2 2025.
- In Q2 2025, Interest Expenses fell 56.64% year-over-year to $3.4 million; the TTM figure through Jun 2025 stood at $3.4 million (down 56.64% YoY), while the FY2025 annual figure was $322.1 million, up 7.61% from the prior year.
- Interest Expenses retreated to $3.4 million in Q2 2025 per HCM's latest filing, from $7.9 million in the prior quarter.
- Across five years, Interest Expenses topped out at $7.9 million in Q2 2024 and bottomed at $1.5 million in Q2 2023.
- Historically, Interest Expenses has averaged $4.1 million across 4 years, with a median of $3.5 million in 2022.
- Annual changes were most pronounced in 2023 — Interest Expenses slumped 57.17% — and 2024, when it surged 413.3%.
- HUTCHMED (China)'s Interest Expenses stood at $3.6 million in 2022, then plunged by 57.17% to $1.5 million in 2023, then soared by 413.3% to $7.9 million in 2024, then plunged by 56.64% to $3.4 million in 2025.
- Business Quant data shows HCM's Interest Expenses at $3.4 million in Q2 2025, $7.9 million in Q2 2024, and $1.5 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Jun 30, 2026 | 5,000.00 |
| Jun 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Jun 30, 2024 | 7.91 Mn |
| Jun 30, 2024 | 7.91 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Dec 31, 2020 | 122.38 Mn |
| Dec 31, 2020 | 122.38 Mn |
| Mar 31, 2020 | -3,000.00 |
| Mar 31, 2020 | -3,000.00 |
| Dec 31, 2019 | 146,000.00 |
| Dec 31, 2019 | 146,000.00 |
| Sep 30, 2019 | 7.44 Mn |
| Sep 30, 2019 | 7.44 Mn |
| Jun 30, 2019 | 7.71 Mn |
| Jun 30, 2019 | 7.71 Mn |